Insmed Incorporated · XETR:IM8N
Insmed Incorporated shareholders
As of Sep 30, 2026, 689 institutions reported holding Insmed Incorporated, 99.9% of its shares. Largest: Vanguard, BlackRock and Fidelity. New holders, exits, insiders and big stakes, each with its filing.
Shareholders
Institutions
| Holder | Shares | Of the company | Value | Change vs Jun 30 | Filed |
|---|---|---|---|---|---|
| Vanguard | 22.5M | 10.2% | US$2.56B | +214K | Nov 16, 2026 |
| BlackRock | 15.9M | 7.3% | US$1.82B | +101K | Nov 13, 2026 |
| Fidelity | 15.5M | 7.1% | US$1.77B | −625K | Nov 10, 2026 |
| Capital Group | 9.35M | 4.3% | US$1.07B | +1.11M | Nov 12, 2026 |
| Baker Bros. Advisors LP | 8.8M | 4.0% | US$1B | No change | Nov 16, 2026 |
| JPMorgan | 8.24M | 3.8% | US$953M | −2.18M | Nov 12, 2026 |
| Orbis Allan Gray Ltd | 6.73M | 3.1% | US$769M | +657K | Nov 16, 2026 |
| Ameriprise | 6.25M | 2.8% | US$713M | +71,445 | Nov 16, 2026 |
| State Street | 6.16M | 2.8% | US$703M | +110K | Nov 12, 2026 |
| Artisan Partners Limited Partnership | 5.58M | 2.5% | US$637M | +136K | Nov 13, 2026 |
| AQR Capital Management LLC | 5.21M | 2.4% | US$595M | +4.6M | Nov 16, 2026 |
| T. Rowe Price | 4.82M | 2.2% | US$551M | −203K | Nov 16, 2026 |
| Janus Henderson | 4.31M | 2.0% | US$492M | First report | Nov 16, 2026 |
| Geode Capital | 4.15M | 1.9% | US$473M | −68,074 | Nov 6, 2026 |
| D. E. Shaw & Co., Inc. | 3.84M | 1.8% | US$439M | −2.03M | Nov 16, 2026 |
| Rtw Investments, LP | 3.1M | 1.4% | US$353M | −1.75M | Nov 16, 2026 |
| Franklin Templeton | 2.93M | 1.3% | US$325M | −63,380 | Nov 12, 2026 |
| UBS | 2.73M | 1.2% | US$311M | −1.19M | Nov 16, 2026 |
| Vestal Point Capital, LP | 2.73M | 1.2% | US$311M | +2.48M | Nov 16, 2026 |
| Paradigm Biocapital Advisors LP | 2.7M | 1.2% | US$308M | +1.37M | Nov 16, 2026 |
| Castle Hook Partners LP | 2.56M | 1.2% | US$292M | +1.56M | Nov 16, 2026 |
| Maverick Capital LTD | 2.52M | 1.1% | US$288M | +371K | Nov 16, 2026 |
| Pictet Asset Management Holding SA | 1.76M | 0.80% | US$201M | +537K | Nov 3, 2026 |
| Polar Capital Holdings Plc | 1.75M | 0.80% | US$200M | +863K | Nov 16, 2026 |
| Integral Health Asset Management, LLC | 1.6M | 0.73% | US$129M | No change | Nov 16, 2026 |
| Westfield Capital Management Co LP | 1.55M | 0.71% | US$177M | −77,062 | Nov 12, 2026 |
| RBC | 1.53M | 0.70% | US$174M | +1.11M | Nov 16, 2026 |
| Bellevue Group AG | 1.51M | 0.69% | US$172M | +115K | Nov 16, 2026 |
| Deep Track Capital, LP | 1.35M | 0.62% | US$154M | New | Nov 16, 2026 |
| Northern Trust | 1.3M | 0.59% | US$149M | −12,363 | Nov 16, 2026 |
| BNY | 1.29M | 0.59% | US$147M | −22,253 | Nov 5, 2026 |
| Assenagon Asset Management S.A. | 1.27M | 0.58% | US$145M | +830K | Oct 15, 2026 |
| Amundi | 1.25M | 0.57% | US$143M | +766K | Nov 6, 2026 |
| Adage Capital Partners Gp, L.L.C. | 1.25M | 0.57% | US$143M | +400K | Nov 16, 2026 |
| Sei Investments Co | 1.21M | 0.55% | US$138M | +193K | Nov 10, 2026 |
| Morgan Stanley | 1.16M | 0.53% | US$132M | −75,688 | Nov 13, 2026 |
| BNP Paribas | 1.1M | 0.50% | US$125M | +223K | Nov 12, 2026 |
| Duquesne Family Office LLC | 1.09M | 0.50% | US$125M | −332K | Nov 16, 2026 |
| Hood River Capital Management LLC | 1.08M | 0.49% | US$123M | +22,870 | Nov 16, 2026 |
| FIL Ltd | 1.07M | 0.49% | US$123M | +217K | Nov 10, 2026 |
| Schwab | 1.07M | 0.49% | US$122M | −141K | Nov 16, 2026 |
| Holocene Advisors, LP | 1.05M | 0.48% | US$120M | +857K | Nov 16, 2026 |
| Bank of America | 993K | 0.45% | US$113M | −30,079 | Nov 16, 2026 |
| Qube Research & Technologies Ltd | 987K | 0.45% | US$113M | −695K | Nov 13, 2026 |
| Railway Pension Investments Ltd | 869K | 0.40% | US$99.1M | +264K | Nov 13, 2026 |
| Fiera Capital Corp | 866K | 0.39% | US$98.8M | +22,847 | Nov 6, 2026 |
| Jennison Associates LLC | 857K | 0.39% | US$97.8M | −48,345 | Nov 13, 2026 |
| Jane Street | 820K | 0.37% | US$93.7M | +627K | Nov 12, 2026 |
| abrdn | 810K | 0.37% | US$92.4M | +232K | Nov 10, 2026 |
| Legal & General | 793K | 0.36% | US$90.5M | −33,342 | Nov 16, 2026 |
This page holds 50 of 689 holders.
Funds
| Holder | Shares | Of the company | Value | Change | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 6.88M | 3.1% | US$734M | +34,270 | Jun 30, 2026 |
| Growth Fund of America | 6.25M | 2.9% | US$669M | +2.81M | May 31, 2026 |
| JPMorgan Large Cap Growth Fund | 2.79M | 1.3% | US$297M | −7.84M | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 2.49M | 1.1% | US$265M | +1,238 | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 2.49M | 1.1% | US$265M | +105K | Jun 30, 2026 |
| Vanguard Mid-Cap Index Fund | 2.35M | 1.1% | US$250M | +20,640 | Jun 30, 2026 |
| Vanguard Growth Index Fund | 1.8M | 0.82% | US$192M | +277K | Jun 30, 2026 |
| iShares Biotechnology ETF | 1.52M | 0.69% | US$162M | −66,568 | Jun 30, 2026 |
| JPMorgan Mid Cap Growth Fund | 1.43M | 0.65% | US$153M | −116K | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 1.43M | 0.65% | US$153M | +42,522 | Jun 30, 2026 |
| JPMorgan Growth Advantage Fund | 1.38M | 0.63% | US$147M | −128K | Jun 30, 2026 |
| iShares Russell Mid-Cap Growth ETF | 1.27M | 0.58% | US$135M | −51,771 | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 1.26M | 0.57% | US$135M | +274K | May 31, 2026 |
| Select Biotechnology Portfolio | 1.11M | 0.51% | US$119M | +298K | May 31, 2026 |
| Fidelity Extended Market Index Fund | 1.1M | 0.50% | US$117M | −18,567 | May 31, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 1.08M | 0.49% | US$116M | +476K | Jun 30, 2026 |
| Growth Fund | 1.03M | 0.47% | US$110M | +274K | Jun 30, 2026 |
| Invesco NASDAQ 100 ETF | 916K | 0.42% | US$97.9M | +105K | May 31, 2026 |
| Fidelity Advisor Growth Opportunities Fund | 905K | 0.41% | US$96.8M | +539K | May 31, 2026 |
| iShares Russell Mid-Cap ETF | 881K | 0.40% | US$93.9M | +79,887 | Jun 30, 2026 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 864K | 0.39% | US$92.1M | New | Jun 30, 2026 |
| Fidelity Puritan Fund | 849K | 0.39% | US$90.8M | +97,900 | May 31, 2026 |
| Vanguard Mid-Cap Growth Index Fund | 830K | 0.38% | US$88.5M | +10,493 | Jun 30, 2026 |
| iShares Russell 1000 Growth ETF | 819K | 0.37% | US$87.3M | +27,830 | Jun 30, 2026 |
| Fidelity Mid Cap Index Fund | 813K | 0.37% | US$80.1M | +37,133 | Jul 31, 2026 |
| SMALLCAP World Fund Inc | 717K | 0.33% | US$76.4M | −139K | Jun 30, 2026 |
| Artisan Mid Cap Fund | 709K | 0.32% | US$75.6M | −84,109 | Jun 30, 2026 |
| Fidelity Advisor Biotechnology Fund | 680K | 0.31% | US$67.1M | +191K | Jul 31, 2026 |
| Heritage Fund | 647K | 0.29% | US$63.8M | −61,701 | Jul 31, 2026 |
| Vanguard Health Care Index Fund | 640K | 0.29% | US$68.5M | +5,497 | May 31, 2026 |
| Bridge Builder Small/Mid Cap Growth Fund | 603K | 0.28% | US$64.3M | −58,249 | Jun 30, 2026 |
| Columbia Cornerstone Growth Fund | 587K | 0.27% | US$57.9M | +187K | Jul 31, 2026 |
| Fidelity Growth Company Fund | 566K | 0.26% | US$60.6M | +53,300 | May 31, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 548K | 0.25% | US$58.5M | −154K | Jun 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 508K | 0.23% | US$54.2M | −81,665 | Jun 30, 2026 |
| Columbia Contrarian Core Fund | 507K | 0.23% | US$54.2M | New | May 31, 2026 |
| Fidelity Advisor Equity Growth Fund | 502K | 0.23% | US$53.7M | +45,200 | May 31, 2026 |
| Select Health Care Portfolio | 500K | 0.23% | US$53.5M | −60,000 | May 31, 2026 |
| T. Rowe Price All-Cap Opportunities Fund | 462K | 0.21% | US$49.2M | +191K | Jun 30, 2026 |
| Schwab U.S. Large-Cap Growth ETF | 455K | 0.21% | US$48.6M | +45,404 | May 31, 2026 |
| VIP Growth Portfolio | 435K | 0.20% | US$46.4M | −17,600 | Jun 30, 2026 |
| JPMorgan Active Growth ETF | 421K | 0.19% | US$44.9M | −289K | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 404K | 0.18% | US$43.2M | +4,580 | May 31, 2026 |
| Eventide Healthcare & Life Sciences Fund | 403K | 0.18% | US$43M | +36,241 | Jun 30, 2026 |
| BlackRock Health Sciences Opportunities Portfolio | 392K | 0.18% | US$41.9M | +90,796 | May 29, 2026 |
| JNL/JPMorgan MidCap Growth Fund | 392K | 0.18% | US$41.8M | −34,599 | Jun 30, 2026 |
| Hood River Small-Cap Growth Fund | 387K | 0.18% | US$41.2M | +119K | Jun 30, 2026 |
| Fidelity OTC Portfolio | 384K | 0.18% | US$37.9M | No change | Jul 31, 2026 |
| Vanguard Explorer Fund | 381K | 0.17% | US$37.6M | −325K | Jul 31, 2026 |
| Carillon Eagle Mid Cap Growth Fund | 374K | 0.17% | US$39.9M | −17,034 | Jun 30, 2026 |
This page holds 50 of 623 holders.
Big stakes
| Holder | Stake | Shares | Date |
|---|---|---|---|
| FMR LLC | 7.40% | 16.1M | Jun 30, 2026 |
| BlackRock, Inc. | 6.60% | 14.1M | Dec 31, 2025 |
| Vanguard Capital Management LLC | 5.34% | 11.5M | Mar 31, 2026 |